Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000411561 | SCV000553781 | pathogenic | Bardet-Biedl syndrome | 2016-12-15 | criteria provided, single submitter | clinical testing | While this particular variant has not been reported in the literature, loss-of-function variants in BBS1 are known to be pathogenic (PMID: 12118255). For these reasons, this variant has been classified as Pathogenic. This sequence change deletes 1 nucleotide from exon 11 of the BBS1 mRNA (c.1072delT), causing a frameshift at codon 358. This creates a premature translational stop signal (p.Tyr358Ilefs*16) and is expected to result in an absent or disrupted protein product. |
Counsyl | RCV000709659 | SCV000485836 | likely pathogenic | Bardet-Biedl syndrome 1 | 2016-02-19 | no assertion criteria provided | clinical testing |